Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001698530-20-000076
Filing Date
2020-11-12
Accepted
2020-11-12 08:11:25
Documents
82
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xcur-20200930.htm   iXBRL 10-Q 1899530
2 EX-10.2 exicureexhibit102-93020.htm EX-10.2 67420
3 EX-31.1 exicureexhibit311-93020.htm EX-31.1 8130
4 EX-32.1 exicureexhibit321-93020.htm EX-32.1 6787
10 xcur-20200930_g1.jpg GRAPHIC 419691
11 xcur-20200930_g2.jpg GRAPHIC 202561
  Complete submission text file 0001698530-20-000076.txt   9060073

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20200930.xsd EX-101.SCH 49967
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xcur-20200930_cal.xml EX-101.CAL 92758
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xcur-20200930_def.xml EX-101.DEF 225224
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20200930_lab.xml EX-101.LAB 630006
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20200930_pre.xml EX-101.PRE 406710
12 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20200930_htm.xml XML 1192481
Mailing Address 8045 LAMON AVE, SUITE 410 SKOKIE IL 60077
Business Address 8045 LAMON AVE, SUITE 410 SKOKIE IL 60077 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39011 | Film No.: 201303512
SIC: 2834 Pharmaceutical Preparations